Lecithin-based Microemulsions for Targeted Delivery of Ceramide AP into the Stratum Corneum: Formulation, Characterizations, and in Vitro Release and Penetration Studies
Overview
Affiliations
Purpose: To improve the solubility and penetration of Ceramide AP (CER [AP]) into the stratum corneum that potentially restores the barrier function of aged and affected skin.
Methods: CER [AP] microemulsions (MEs) were formulated using lecithin, Miglyol® 812 (miglyol) and water-1,2 pentandiol (PeG) mixture as amphiphilic, oily and hydrophilic components, respectively. The nanostructure of the MEs was revealed using electrical conductivity, differential scanning calorimeter (DSC) and electron paramagnetic resonance (EPR) techniques. Photon correlation spectroscopy (PCS) was used to measure the sizes and shape of ME droplets. The release and penetration of the CER into the stratum corneum was investigated in vitro using a multi-layer membrane model.
Results: The MEs exhibited excellent thermodynamic stability (>2 years) and loading capacity (0.5% CER [AP]). The pseudo-ternary phase diagrams of the MEs were obtained and PCS results showed that the droplets are spherical in shape and bigger in size. In vitro investigations showed that the MEs exhibited excellent rate and extent of release and penetration.
Conclusions: Stable lecithin-based CER [AP] MEs that significantly enhance the solubility and penetration of CER [AP] into the stratum corneum were developed. The MEs also have better properties than the previously reported polyglycerol fatty acid surfactant-based CER [AP] MEs.
Strati F, Mukhina T, Neubert R, Opalka L, Hause G, Schmelzer C BBA Adv. 2023; 2:100039.
PMID: 37082599 PMC: 10074917. DOI: 10.1016/j.bbadva.2021.100039.
Microemulsions as Solubilizers and Penetration Enhancers for Minoxidil Release from Gels.
Spaglova M, cuchorova M, cierna M, Ponist S, Bauerova K Gels. 2021; 7(1).
PMID: 33802416 PMC: 7931056. DOI: 10.3390/gels7010026.
The Phospholipid Research Center: Current Research in Phospholipids and Their Use in Drug Delivery.
Drescher S, van Hoogevest P Pharmaceutics. 2020; 12(12).
PMID: 33353254 PMC: 7766331. DOI: 10.3390/pharmaceutics12121235.
Design strategies for programmable oligonucleotide nanotherapeutics.
Sahle F, Lowe T Drug Discov Today. 2019; 25(1):73-88.
PMID: 31525462 PMC: 6980509. DOI: 10.1016/j.drudis.2019.09.006.
Nanocarrier-based systems for targeted and site specific therapeutic delivery.
Majumder J, Taratula O, Minko T Adv Drug Deliv Rev. 2019; 144:57-77.
PMID: 31400350 PMC: 6748653. DOI: 10.1016/j.addr.2019.07.010.